5i Research Weekly Rockets and Duds
Hey Santa, where is the Santa Claus Rally? It sure wasn't there last week, as investors fretted over lots of things. A rate cut in the USA helped, a bit, but it was still a volatile week.
Here are some big movers we noted for the week.
EchoStar Corporation SATS
EchoStar again makes our Rockets list, with a 31% gain last week. It's been on our list a few times this year, considering its 369% gain on the year now, with still two weeks left to go. Last week was a big week for 'Space' stocks, which, um, rocketed higher on news that SpaceX was in fact going to be doing its IPO next year. With a valuation expected to be north of $1 trillion, the entire space sector, which is not that big, um, took off. They say it's cold in space. But maybe to stay warm, astronauts can just burn some of the money they have made on space stocks this year. But wait, there's no oxygen in space. How will that work? I knew I should have paid more attention in high school. Anyway, space stocks have um, reached the stratosphere.
EchoStar Corporation SATS
EchoStar again makes our Rockets list, with a 31% gain last week. It's been on our list a few times this year, considering its 369% gain on the year now, with still two weeks left to go. Last week was a big week for 'Space' stocks, which, um, rocketed higher on news that SpaceX was in fact going to be doing its IPO next year. With a valuation expected to be north of $1 trillion, the entire space sector, which is not that big, um, took off. They say it's cold in space. But maybe to stay warm, astronauts can just burn some of the money they have made on space stocks this year. But wait, there's no oxygen in space. How will that work? I knew I should have paid more attention in high school. Anyway, space stocks have um, reached the stratosphere. 
Wave Life Sciences Ltd. WVE So we all know that obesity drugs have been a thing. Companies such as Novo and Lily have seen huge sales boosts as fat-America tries to slim down with drugs. But, now, how about just turning fat into muscle? Wave Life shares soared 121% last week as Phase I results showed its drug has success in 'improving body composition'. While total body mass in its trial patients did not change, the mix of muscle to fat improved, with more muscle. Analysts say that, while it is only an early stage trial, Wave Life's drug could be 'disruptive' to the entire obesity-drug sector. The company used its new-found success to raise $350 million for further studies. So, should I go to the gym today or what? It looks like one day you will be able to eat bowls of ice cream all day and still look good with more muscles. We can only dream.
So we all know that obesity drugs have been a thing. Companies such as Novo and Lily have seen huge sales boosts as fat-America tries to slim down with drugs. But, now, how about just turning fat into muscle? Wave Life shares soared 121% last week as Phase I results showed its drug has success in 'improving body composition'. While total body mass in its trial patients did not change, the mix of muscle to fat improved, with more muscle. Analysts say that, while it is only an early stage trial, Wave Life's drug could be 'disruptive' to the entire obesity-drug sector. The company used its new-found success to raise $350 million for further studies. So, should I go to the gym today or what? It looks like one day you will be able to eat bowls of ice cream all day and still look good with more muscles. We can only dream. 
Trulieve Cannabis Corp. TRUL TRUL shares soared HIGHER last week as President Trump indicated he would be easing federal marijuana restrictions. TRUL shares hit a new HIGH. Shares look to go HIGHER this week. Trulieve also sold $100 million in HIGH-yield notes last week, and opened a new location in Findlay, Ohio, otherwise known as O-HIGH-O. Seriously, this stuff just writes itself sometimes.
TRUL shares soared HIGHER last week as President Trump indicated he would be easing federal marijuana restrictions. TRUL shares hit a new HIGH. Shares look to go HIGHER this week. Trulieve also sold $100 million in HIGH-yield notes last week, and opened a new location in Findlay, Ohio, otherwise known as O-HIGH-O. Seriously, this stuff just writes itself sometimes. 
Fermi Inc. FRMI 
Fermi, run by former US Energy Secretary Rick Perry, fell 33% last week as it disclosed that a major $150 million tenant at its Texas data centre campus has terminated its agreement. The tenancy was expected to provide $1 billion in revenue annually. For investors, this highlights the difference between a 'letter of intent', which is what the company had, and a 'contract', which is what it did not have. Shareholders are wondering why they paid $21 per share in Fermi's IPO, just two months ago, with the shares now at $10.
Fermi, run by former US Energy Secretary Rick Perry, fell 33% last week as it disclosed that a major $150 million tenant at its Texas data centre campus has terminated its agreement. The tenancy was expected to provide $1 billion in revenue annually. For investors, this highlights the difference between a 'letter of intent', which is what the company had, and a 'contract', which is what it did not have. Shareholders are wondering why they paid $21 per share in Fermi's IPO, just two months ago, with the shares now at $10. 
Bloom Energy BE Energy shares have been very hot this year, tied to the growth of the AI sector. Bloom shares are up 328% this year. But when the sector cools, investors are quick to take the stock from 'Blooming' to 'Plucking'. Shares fell 20% last week as investors fretted about AI growth, following some uncertainty at Oracle and Broadcom. We are sure shareholders will survive the dip, which occurred on absolutely no news from the company itself.
Energy shares have been very hot this year, tied to the growth of the AI sector. Bloom shares are up 328% this year. But when the sector cools, investors are quick to take the stock from 'Blooming' to 'Plucking'. Shares fell 20% last week as investors fretted about AI growth, following some uncertainty at Oracle and Broadcom. We are sure shareholders will survive the dip, which occurred on absolutely no news from the company itself. 
Take Care,
Unlock the Power of Informed Investing with 5i Research!
DIY investing doesn't have to mean going it alone. At 5i Research, we're your trusted partner in navigating the stock market. Our platform offers comprehensive stock and market research, empowering you to make smart investment decisions.
- Investor Q&A: Have burning questions? Get answers from our team of experts and fellow investors in our dedicated Q&A section.
- Research Reports: With over 60 meticulously researched Canadian stocks, our reports offer in-depth analysis, giving you the confidence to invest wisely.
- Model Portfolios, Alerts, Forums, Portfolio Tracking, and Much More..
Analysts of 5i Research responsible for this report do not have a financial or other interest in securities mentioned. The i2i Fund does not have a financial or other interest in securities mentioned.
Comments
Login to post a comment.